This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Prevention

Authoring team

Prevention of enteric fever includes:

  • reducing the risk of contamination of food and drink by ensuring a safe water supply and improved sanitation. Unfortunately for travellers, few maintain good standards of hygiene
  • immunisation to S. typhi may be performed on a mass scale though this may be overcome by a large inoculum of S.typhi. Also, a vaccine for S. paratyphi is not available (1,2)
  • immunisation is recommended for travellers to most countries in the developing world and for laboratory workers handling specimens from suspected cases (1)
  • Vi polysaccharide vaccine and Ty21a vaccine are available for use in travellers. The typhoid Vi conjugate vaccine is now recommended by the WHO
    in endemic areas (2)
    • Ty21a is a live attenuated oral vaccine. Fever was more common following Ty21a vaccination compared with placebo
    • Vi capsular polysacchride vaccine (ViPS) is given as a single injection
    • re-vaccination is recommended after three years with both these vaccines
    • both these vaccines are of limited value in preschool children because of difficulties of administration (Ty21a oral capsules) or inferior immune response (ViPS)

Repeated exposure to infection gives adults a greater degree of natural immunity.

Reference:

  1. GP magazine (September 24th 2004): 44.
  2. Basnyat B et al. Enteric Fever. BMJ 2021;372:n437 http://dx.doi.org/10.1136/bmj.n437

Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.